HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aesthetic Medicine

688.562

-7.784-1.12%

Number of Gainers:4

Number of Losers:6

Number of Flat:3

PE:- -

High:701.617

Open:697.082

Low:683.143

Close:696.346

Loading ...

Fosun Pharma Makes Senior Management Changes

MT Newswires Live

Shanghai Fosun Pharmaceutical's Q1 Profit Jumps 25%; Hong Kong Shares Slide 4%

MT Newswires Live

BRIEF-Sihuan Pharma Repurchases Total Of 1.9 Million Shares

Sihuan Pharma - Repurchased Total of 1.9 Mln Shares of Co on Market at Average Price of HK$0.69 per Share

THOMSON REUTERS

BRIEF-Sihuan Pharma Will Conduct On-Market Share Repurchase Of Up To HK$500 Million In Aggregate

Sihuan Pharma - Will Conduct on-Market Share Repurchase of up to HK$500 Mln in Aggregate

THOMSON REUTERS

Haohai Biological Technology's Q1 Profit Slides 7%

MT Newswires Live

Sihuan Pharmaceutical Unit's Diabetes Drug Gets Registration Approval in China

MT Newswires Live

BRIEF-Sihuan Pharma Says Dapagliflozin Tablets Obtained Drug Registration Approval From NMPA

Sihuan Pharma - Dapagliflozin Tablets Developed by Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa

THOMSON REUTERS

BRIEF-China Medical System Announces Proposed Spin-Off And Separate Listing Of Dermavon Holdings

China Medical System Holdings - Proposed Spin-off and Separate Listing of Dermavon Holdings Limited

THOMSON REUTERS

3SBio's Lung Cancer Drug Gets Breakthrough Therapy Designation in China

MT Newswires Live

BRIEF-3Sbio Says 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation By NMPA

3SBio - 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS

BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per Share

Sihuan Pharma - Repurchased 10 Mln Shares at Average Price of HK$0.6274 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":688.5618,"timestamp":1746000495768,"preClose":696.34595,"halted":0,"volume":104740800,"delay":0,"changeRate":-0.011179,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed Labour Day","change":-7.784119,"latestTime":"04-30 16:00:00","open":697.0822,"high":701.6172,"low":683.14325,"amount":647892482,"amplitude":0.02653,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"pbRate":1.205984,"peRate":18.340965,"turnoverRate":0.005095,"increases":4,"decrements":6,"flats":3,"marketCap":117115448592,"floatMarketCap":82728321936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":701.6172,"amplitude":0.02653,"preClose":696.34595,"low":683.14325,"pbRate":"1.205984","latestPrice":688.5618,"volume":104740800,"delay":0,"open":697.0822,"prevYearClose":571.87146,"prevWeekClose":717.241,"prevMonthClose":688.562,"prevQuarterClose":677.607,"fiveDayClose":711.287,"twentyDayClose":701.326,"sixtyDayClose":538.497,"secType":"PLATE","market":"HK","turnoverRate":0.005095,"peRate":18.340965,"marketCap":117115448592,"floatMarketCap":82728321936,"timestamp":1746000495768,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":4,"down":6,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531036840","title":"Fosun Pharma Makes Senior Management Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2531036840","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531036840?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:38","pubTimestamp":1746013128,"startTime":"0","endTime":"0","summary":"Wu Yifang resigned as Shanghai Fosun Pharmaceutical's  chairman due to the adjustment of work arrangements effective Tuesday, a same-day Hong Kong bourse filing said.Wu has also been redesignated from an executive director to a non-executive director.Co-Chair Wang Kexin also stepped down the same day due to work adjustment, but will continue serving as an executive director.The pharmaceutical firm, on the same day, named Chen Yuqing as chairman, after he was redesignated from a non-executive director to an executive director; Guan Xiaohui as co-chairman; and Wen Deyong as vice chairman","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00656","BK1593","BK0060","BK1515","BK0188","BK0239","BK0187","BK0196","600196","BK1191","02196","BK0028","BK0096","BK0175","BK1230","BK0183","BK0012"],"gpt_icon":0},{"id":"2531706371","title":"Shanghai Fosun Pharmaceutical's Q1 Profit Jumps 25%; Hong Kong Shares Slide 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531706371","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531706371?lang=en_us&edition=fundamental","pubTime":"2025-04-30 15:50","pubTimestamp":1745999420,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical's  attributable profit rose 25% to 764.8 million yuan in the first quarter from 609.7 million yuan in the year-ago period, according to a Tuesday filing with the Hong Kong bourse.Earnings per share at the drug company increased 26% to 0.29 yuan from 0.23 yuanin the year-ago period.Operating income declined 7.3% to 9.42 billion yuan from 10.2 billion yuan in the prior-year period.Shares slipped 4% in Hong Kong during afternoon trading on Wednesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00656","BK0060","BK0188","BK1593","BK0239","BK0028","BK0183","BK0096","BK0175","BK1191","600196","BK1230","BK1515","BK0196","BK0187","02196","BK0012"],"gpt_icon":0},{"id":"2531890167","title":"BRIEF-Sihuan Pharma Repurchases Total Of 1.9 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2531890167","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531890167?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:20","pubTimestamp":1745925649,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Repurchases Total Of 1.9 Million SharesApril 29 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:REPURCHASED TOTAL OF 1.9 MILLION SHARES OF CO ON MARKET AT AVERAGE PRICE OF HK$0.69 PER SHAREFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R70WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","BK1593","BK1515","BK1600"],"gpt_icon":0},{"id":"2531614786","title":"Sihuan Pharma -  Repurchased Total of 1.9 Mln Shares of Co on Market at Average Price of HK$0.69 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2531614786","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531614786?lang=en_us&edition=fundamental","pubTime":"2025-04-29 19:02","pubTimestamp":1745924553,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R70WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1515","00460","BK1191","BK1593"],"gpt_icon":0},{"id":"2530236843","title":"BRIEF-Sihuan Pharma Will Conduct On-Market Share Repurchase Of Up To HK$500 Million In Aggregate","url":"https://stock-news.laohu8.com/highlight/detail?id=2530236843","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530236843?lang=en_us&edition=fundamental","pubTime":"2025-04-28 23:19","pubTimestamp":1745853590,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Will Conduct On-Market Share Repurchase Of Up To HK$500 Million In AggregateApril 28 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:WILL CONDUCT ON-MARKET SHARE REPUR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R61LA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","00460","BK1191","BK1600","BK1515"],"gpt_icon":0},{"id":"2530407439","title":"Sihuan Pharma -  Will Conduct on-Market Share Repurchase of up to HK$500 Mln in Aggregate","url":"https://stock-news.laohu8.com/highlight/detail?id=2530407439","media":"THOMSON REUTERS","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530407439?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:57","pubTimestamp":1745845062,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nFWN3R61LA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1600","00460","BK1593"],"gpt_icon":0},{"id":"2530476259","title":"Haohai Biological Technology's Q1 Profit Slides 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530476259","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530476259?lang=en_us&edition=fundamental","pubTime":"2025-04-28 18:42","pubTimestamp":1745836968,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology  recorded a 7% decline in attributable profit in the first quarter to 90.3 million yuan from 97.5 million yuan in the year-ago period, a Friday Hong Kong bourse filing said.Earnings per share were 0.39 yuan in the quarter, down from 0.42 yuan in the corresponding period of the last fiscal year.The ophthalmic products manufacturer's revenue fell 4.3% to 618.5 million yuan in the three months from 646 million yuan a year prior.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","06826","BK1161"],"gpt_icon":0},{"id":"2529672710","title":"Sihuan Pharmaceutical Unit's Diabetes Drug Gets Registration Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2529672710","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529672710?lang=en_us&edition=fundamental","pubTime":"2025-04-24 17:36","pubTimestamp":1745487415,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration granted drug registration approval for Sihuan Pharmaceutical  subsidiary Huisheng Biopharmaceutical's Dapagliflozin tablets for the treatment of type 2 diabetes in adult patients.The medication also passed China's consistency evaluation of quality and efficacy of generic drugs, according to a Wednesday filing with the Hong Kong Exchange.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00460","BK1515","BK1600","BK1593","BK1191"],"gpt_icon":0},{"id":"2529631655","title":"BRIEF-Sihuan Pharma Says Dapagliflozin Tablets Obtained Drug Registration Approval From NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2529631655","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529631655?lang=en_us&edition=fundamental","pubTime":"2025-04-23 23:26","pubTimestamp":1745421990,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Says Dapagliflozin Tablets Obtained Drug Registration Approval From NMPAApril 23 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:DAPAGLIFLOZIN TABLETS DEVELOPED BY HUI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R10YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"2529050052","title":"Sihuan Pharma - Dapagliflozin Tablets Developed by Huisheng Biopharmaceutical Obtained Drug Registration Approval From Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2529050052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529050052?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:38","pubTimestamp":1745411923,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R10YT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1593","00460","BK1191","BK1515"],"gpt_icon":0},{"id":"2529446532","title":"BRIEF-China Medical System Announces Proposed Spin-Off And Separate Listing Of Dermavon Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2529446532","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529446532?lang=en_us&edition=fundamental","pubTime":"2025-04-23 01:08","pubTimestamp":1745341717,"startTime":"0","endTime":"0","summary":"BRIEF-China Medical System Announces Proposed Spin-Off And Separate Listing Of Dermavon HoldingsApril 22  - China Medical System Holdings Ltd 0867.HK:PROPOSED SPIN-OFF AND SEPARATE LISTING OF DERMAVON HOLDINGS LIMITEDSEPARATE LISTING OF DERMAVON HOLDINGS ON MAIN BOARD OF STOCK EXCHANGE OF HONG KONGFurther company coverage: 0867.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R0235:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","00867","SG9999015986.USD","LU2488822045.USD","SG9999015945.SGD","SG9999015952.SGD","SG9999004220.SGD","IE00BYV24P56.USD","BK1191","IE00BMCWC346.EUR","BK1593"],"gpt_icon":0},{"id":"2529583276","title":"China Medical System Holdings - Proposed Spin-off and Separate Listing of Dermavon Holdings Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2529583276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529583276?lang=en_us&edition=fundamental","pubTime":"2025-04-22 21:32","pubTimestamp":1745328772,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R0235:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","IE00BMCWC346.EUR","IE00BYV24P56.USD","00867","LU2488822045.USD","SG9999004220.SGD","SG9999015986.USD","SG9999015952.SGD","BK1593","SG9999015945.SGD","SG9999015978.USD"],"gpt_icon":0},{"id":"2528508155","title":"3SBio's Lung Cancer Drug Gets Breakthrough Therapy Designation in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2528508155","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528508155?lang=en_us&edition=fundamental","pubTime":"2025-04-18 12:19","pubTimestamp":1744949994,"startTime":"0","endTime":"0","summary":"3SBio  said its 707 injection was granted a breakthrough therapy designation by China's National Medical Products Administration, according to a late Thursday bourse filing.This designation provides benefits for 707's development as a first-line treatment for PD-L1-positive locally advanced or metastatic non-small cell lung cancer, the filing stated.Drugs with that designation are entitled to policy support, prioritized communication resources, enhanced guidance, and accelerated development.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","BK1583","BK1161","01530"],"gpt_icon":0},{"id":"2528919794","title":"BRIEF-3Sbio Says 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2528919794","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528919794?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:29","pubTimestamp":1744885740,"startTime":"0","endTime":"0","summary":"BRIEF-3Sbio Says 707 Injection  Granted Breakthrough Therapy Designation By NMPAApril 17  - 3SBio Inc 1530.HK:707 INJECTION  GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPAFurther company coverage: 1530.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QU2L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01530","BK1583","BK1593"],"gpt_icon":0},{"id":"2528769933","title":"3SBio -  707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2528769933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528769933?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:32","pubTimestamp":1744878747,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QU2L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01530","BK1583","BK1161","BK1593"],"gpt_icon":0},{"id":"2527288402","title":"BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2527288402","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527288402?lang=en_us&edition=fundamental","pubTime":"2025-04-16 23:18","pubTimestamp":1744816681,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per ShareApril 16 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:REPURCHASED 10 MILLION SHARES AT AVERAGE PRICE OF HK$0.6274 PER SHAREFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1515","BK1191","00460","BK1600"],"gpt_icon":0},{"id":"2527962852","title":"Sihuan Pharma - Repurchased 10 Mln Shares at Average Price of HK$0.6274 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2527962852","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527962852?lang=en_us&edition=fundamental","pubTime":"2025-04-16 18:40","pubTimestamp":1744800030,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1600","BK1191","BK1515","00460","BK1593"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}